Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast
Authors:
Open Access
- 14 November 2023
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 29 (42) , 5751-5767
Abstract
BACKGROUND Inflammatory bowel disease (IBD) is an idiopathic intestinal disease with various levels and trends in different countries and regions. Understanding the current burden and trends of IBD in various geographical locations is essential to establish effective strategies for prevention and treatment. We report the average annual percentage change (AAPC) and estimated annual percentage change (EAPC) in age-standardized rates (ASR) of IBD in different regions based on the Global Burden of Disease (GBD) study from 1990-2019, and the relationships between IBD and the human development index (HDI) and socio-demographic index (SDI). The prevalence trends of IBD were predicted by gender from 2019-2039. AIM To comprehensively investigate IBD data, providing further insights into the management of this chronic disease. METHODS We collected the information on the incidence of IBD from the GBD study from 1990-2019 to calculate the AAPC and EAPC in ASR of IBD in different regions. The relationships between IBD, HDI, and SDI were analyzed. The Nordpred and Bayesian age-period-cohort models were used to predict the prevalence trends of IBD by gender from 2019-2039, and the reliability of the results was validated. Statistics of all the data in this study were performed using R software (version 4.2.1). RESULTS North America consistently had the highest IBD ASR, while Oceania consistently had the lowest. East Asia had the fastest average annual growth in ASR (2.54%), whereas Central Europe had the fastest decline (1.38%). Countries with a low age-standardized incidence rates in 1990 showed faster growth in IBD while there was no significant correlation in 2019. Additionally, IBD increased faster in countries with a low age-standardized death rates in 1990, whereas the opposite was true in 2019. Analysis of SDI and IBD ASR showed that countries with a high SDI generally had a higher IBD ASR. Finally, the projections showed a declining trend in the incidence of IBD from 2019-2039, but a gradual increase in the number of cases. CONCLUSION As the global population increases and ages, early monitoring and prevention of IBD is important to reduce the disease burden, especially in countries with a high incidence of IBD.Keywords
This publication has 48 references indexed in Scilit:
- The global burden of IBD: from 2015 to 2025Nature Reviews Gastroenterology & Hepatology, 2015
- Artificial sweeteners induce glucose intolerance by altering the gut microbiotaNature, 2014
- Predictors and risks for death in a population-based study of persons with IBD in ManitobaGut, 2014
- Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-PacificGut, 2014
- Environmental Risk Factors for Inflammatory Bowel Diseases: A ReviewDigestive Diseases and Sciences, 2014
- Biological therapies in Crohn’s disease: are they cost-effective? A critical appraisal of model-based analysesExpert Review of Pharmacoeconomics & Outcomes Research, 2014
- Microbiota activation and regulation of innate and adaptive immunityImmunological Reviews, 2014
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future AheadGastroenterology, 2014
- A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative ColitisGastroenterology, 2013
- An Investigation of Genome-Wide Studies Reported Susceptibility Loci for Ulcerative Colitis Shows Limited Replication in North IndiansPLOS ONE, 2011